Search Results
May 28, 2026, 21:24 ET Bitmine Immersion Technologies (BMNR) 宣佈其以太幣 (ETH) 持有量達 539 萬枚，加密資產及現金總持有額達 123 億美元
Bitmine 為美國第 193 大最活躍交易股票，日均成交額達 5.72 億美元（5 日平均）Bitmine 持續獲得頂級機構投資者支持，包括 ARK 的 Cathie Wood、MOZAYYX、Founders Fund、Bill Miller III、Pantera、Kraken、DCG、Galaxy Digital 以及個人投資者 Thomas "Tom" Lee，攜手支持 Bitmine 收購 5% 以太幣的目標康州諾沃克2026年5月29日
More news about: Bitmine Immersion Technologies, Inc.
May 28, 2026, 20:35 ET Bitmine Immersion Technologies (BMNR) annuncia che le sue partecipazioni in ETH raggiungono i 5,39 milioni di token e che le partecipazioni totali in criptovalute e liquidità ammontano a 12,3 miliardi di dollari
continua a essere sostenuta da un gruppo di investitori istituzionali di prim'ordine tra cui ARK di Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore privato Thomas "Tom" Lee a sostegno dell'obiettivo di Bitmine di acquisire il 5% di ETH
More news about: Bitmine Immersion Technologies, Inc.
May 28, 2026, 20:14 ET BitMine Immersion Technologies (BMNR) anuncia que suas participações em ETH somam 5,39 milhões de tokens e que o total em criptomoedas e caixa é de US$ 12,3 bilhões
Bitmine continua a ter o apoio de um grupo de investidores institucionais de destaque, incluindo Cathie Wood da ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e o investidor individual Thomas "Tom" Lee, para apoiar a meta da Bitmine de adquirir 5% do ETH
More news about: Bitmine Immersion Technologies, Inc.
May 28, 2026, 19:38 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,39 millones de tokens y sus tenencias totales en criptomonedas y efectivo ascienden a 12.300 millones de dólares
respaldo de un grupo de inversionistas institucionales de primer nivel, entre los que se encuentran Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversionista particular Thomas "Tom" Lee, con el fin de apoyar el objetivo de Bitmine de adquirir el 5 %
More news about: Bitmine Immersion Technologies, Inc.
May 28, 2026, 19:00 ET Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 18 products in the market. It has 5 assets in Phase III or pivotal clinical trials and 14 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly,
More news about: Innovent Biologics
May 28, 2026, 16:40 ET Perimeter Announces First Quarter 2026 Financial Results
material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include,
More news about: Perimeter Medical Imaging AI Inc.
May 28, 2026, 16:30 ET Prologis to Participate in REITWeek 2026: Nareit's Investor Conference
local economic and political climates and conditions; (ii) changes in global financial markets, interest rates and foreign currency exchange rates; (iii) increased or unanticipated competition for our properties; (iv) risks associated with acquisitions, dispositions and development of properties, including
More news about: Prologis, Inc.
May 28, 2026, 16:15 ET Gap Inc. Reports First Quarter Fiscal 2026 Results, Raises Full Year Earnings Per Share Outlook
adjusted statement of operations metrics, including: (i) adjusted operating expenses; (ii) adjusted operating expenses as a percentage of net sales; (iii) adjusted operating income; (iv) adjusted operating margin, (v) adjusted net income; (vi) adjusted income tax expense and (vii) adjusted earnings per
More news about: Gap Inc.
May 28, 2026, 16:05 ET ePlus Reports Fourth Quarter and Fiscal Year 2026 Financial Results
reconciliations below for the following non-GAAP financial measures: (i) Adjusted EBITDA, (ii) Non-GAAP: Net earnings from continuing operations and (iii) Non-GAAP Net earnings from continuing operations per common share - diluted.We define Adjusted EBITDA as net earnings from continuing operations
More news about: EPLUS INC.
May 28, 2026, 15:21 ET What If You're Dreaming More Than You Realize?
artists, and collaborators for conversations that challenge perspectives and deepen connections. Past Spark Salon speakers have included illusionist Harris III, psychologist Scott Barry Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author
More news about: Unlikely Collaborators
May 28, 2026, 13:50 ET ZTS INVESTOR ALERT: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead the Zoetis Class Action Lawsuit
Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (iii) Zoetis' dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment.On August
More news about: Robbins Geller Rudman & Dowd LLP
May 28, 2026, 13:38 ET Bulletin from the Annual General Meeting in BioArctic AB (publ)
relating to the company's research and development and/or partnerships and established by the board of directors (the operational conditions), and (iii) one or more sustainability-related targets set by the board of directors (the sustainability conditions).Fulfilment of the performance criteria
More news about: BioArctic
May 28, 2026, 13:34 ET Bulletin from the Annual General Meeting in BioArctic AB (publ)
relating to the company's research and development and/or partnerships and established by the board of directors (the operational conditions), and (iii) one or more sustainability-related targets set by the board of directors (the sustainability conditions).Fulfilment of the performance criteria
More news about: BioArctic
May 28, 2026, 13:15 ET Braeburn Presents New Data at 2026 ASCP Annual Meeting Demonstrating Opioid Withdrawal Suppression at Low Buprenorphine Plasma Concentrations
solution for injection.WARNINGS AND PRECAUTIONSAddiction, Abuse, and Misuse: BRIXADI contains buprenorphine, a Schedule III controlled substance that can be abused in a manner similar to other opioids. Buprenorphine is sought by people with opioid use disorder and is subject
More news about: Braeburn
May 28, 2026, 12:39 ET /C O R R E C T I O N -- HaloMD/
-- On Friday, May 22nd HaloMD secured a decisive victory in the U.S. District Court for the Eastern District of Texas after Judge Robert W. Schroeder III dismissed with prejudice all seven claims brought by Blue Cross Blue Shield of Texas (BCBS Texas), a division of Chicago-based Health Care Service Corporation
More news about: HaloMD
May 28, 2026, 12:30 ET Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
our partners' ability to deploy new products, services, and applications, and to expand the markets for genomics-related products and services; and (iii) the challenges associated with multiparty collaborations, including our reliance on the performance of such partners, together with other factors detailed
More news about: Illumina, Inc.
May 28, 2026, 10:04 ET Tencent Games Lansir 45 Pengumuman Spektakuler di SPARK 2026, Tegaskan Masa Depan Gaming Generasi Berikutnya
berbasis AI dan konten 3D buatan AI juga turut digunakan. Digital Jingdezhen: Porcelain Craft Adventure segera meluncur di Tiongkok daratan pada Triwulan III- 2026.Era of AscendancyEra of Ascendancy merupakan RPG cultivation bergaya seni tinta Tiongkok yang menawarkan kebebasan
More news about: Tencent Games
May 28, 2026, 10:01 ET Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight
dual mechanism of action. It is currently being studied in Phase III clinical trials for both first- and second-line treatment of immune thrombocytopenia (ITP). As of December 2025, Novartis plans to submit data from the VAYHIT2 Phase III study, along with forthcoming results from the ongoing first-line
More news about: DelveInsight Business Research, LLP
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Pinterest, Inc. and Certain Officers - PINS
States ("U.S.") tariffs on the macroeconomic environment in which the Company operated, including the foreseeable impact on its advertising partners; (iii) the impact of the foregoing on Pinterest's advertising revenues was significant enough that Pinterest was facing and/or likely to face an imminent restructuring;
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP
action] On March 13, 2026, Immutep issued a press release "announc[ing] that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1st line non-small cell lung cancer has recommended the discontinuation of the trial
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Upstart Holdings, Inc. and Certain Officers - UPST
performing its risk-separation processes; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approval rates was overstated; (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results,
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AeroVironment, Inc. and Certain Officers - AVAV
U.S. Space Force's ongoing efforts to modernize the SCN; (ii) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.On January 20, 2026, AeroVironment announced
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
manipulation; (ii) the resulting volatility in the market for the Company's ordinary shares exposed Regencell's investors to significant financial risk; (iii) all the foregoing subjected Regencell to a heightened risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Graphic Packaging Holding Company and Certain Former Officers - GPK
and severity of the foregoing issues, which were likely to, and did, have a material negative impact on the Company's business and financial results; (iii) Defendants likewise overstated the strength and sustainability of the Company's business model and operations, as well as its ability to weather ongoing
More news about: Pomerantz LLP
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Applied Digital did not need the products and services that B&W would purportedly supply pursuant to the Power Generation LNTP and Contract; (iii) the foregoing, at the very least, would raise questions about the parties' actual intent behind entering into the Power Generation LNTP and Contract,
More news about: Pomerantz LLP